A breakthrough study published in Cell identified how the exercise-induced liver enzyme GPLD1 successfully reduces aging-related cognitive decline and Alzheimer’s disease pathology by repairing the blood-brain barrier.
Basic facts
Core Biological Classification:
GPLD1 is a specialized enzyme produced and secreted primarily by the cells of the liver directly into the bloodstream in response to physical activity.
The Exerkine Signaling Network:
It belongs to a newly classified group of signaling molecules known as exerkines—which include peptides, lipids, and hormones released by muscles, the heart, and the liver during exercise to carry health benefits throughout the body.
The Target Barrier Mechanics:
As an enzyme, GPLD1 targets and breaks down specific proteins that accumulate on the blood-brain barrier (a tightly regulated network of protective blood vessels surrounding the brain).
The TNAP Invalidation Pathway:
Aging causes a problematic protein called TNAP to build up in the blood-brain barrier, making the vessels leaky, causing chronic nerve inflammation, and impairing memory systems near the hippocampus. GPLD1 acts as a defense mechanism by breaking down this destructive TNAP protein.
Cognitive Enhancement Markers:
Lab evaluations show that higher concentrations of GPLD1 significantly reduce aging-induced memory defects, allowing older subjects to pass spatial memory tests and recognize novel objects with rates similar to younger peers.
Alzheimer’s Disease Mitigation:
In neurodegenerative models, increasing GPLD1 levels cleared toxic amyloid plaques (harmful protein clumps that destroy nerve cells), stopped vessel leakage, and reversed severe cognitive dysfunction.
Profile
Settings
Refer your friends
Sign out
